Saturday, June 09, 2018 10:49:47 AM
6/8/18, 07:43
07:43 AM EDT, 06/08/2018 (MT Newswires) -- PAVmed (PAVM), a medical device company, said Friday it received subscriptions exceeding the number of rights available to be exercised under an equity subscription rights offering and has accepted all valid subscriptions including up to 9 million units of the total oversubscribed amount.
It expects the rights offering to result in gross proceeds to be received by the company of approximately $10.4 million.
Price: 1.00, Change: +0.03, Percent Change: +3.35
http://www.mtnewswires.com Copyright © 2018 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ok
*Disclosure: My posts are solely for entertainment purposes; mainly my own. Do not take my posts as a recommendation or solicitation to trade any securities. Do your own Due Diligence (DD).
Recent PAVM News
- Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall • PR Newswire (US) • 05/09/2024 11:49:00 AM
- Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors • PR Newswire (US) • 05/07/2024 11:39:00 AM
- PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024 • PR Newswire (US) • 05/03/2024 12:35:00 PM
- Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 • PR Newswire (US) • 05/02/2024 12:35:00 PM
- Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing • PR Newswire (US) • 05/02/2024 11:49:00 AM
- PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute • PR Newswire (US) • 04/30/2024 11:35:00 AM
- Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month • PR Newswire (US) • 04/29/2024 12:47:00 PM
- Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference • PR Newswire (US) • 04/08/2024 12:30:00 PM
- PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/26/2024 11:32:00 PM
- Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population • PR Newswire (US) • 03/21/2024 01:30:00 PM
- PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX • PR Newswire (US) • 03/21/2024 12:30:00 PM
- Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference • PR Newswire (US) • 03/20/2024 12:30:00 PM
- PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024 • PR Newswire (US) • 03/13/2024 12:30:00 PM
- Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024 • PR Newswire (US) • 03/12/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:30:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:49:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:46:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:43:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:41:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:49:05 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/20/2024 09:45:37 PM
- Lucid Diagnostics Provides Update Regarding World Trade Center Health Program • PR Newswire (US) • 02/16/2024 10:00:00 PM
- Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony • PR Newswire (US) • 02/15/2024 12:45:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:30:41 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM